The Good, the Bad, and the Best Jobs - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Good, the Bad, and the Best Jobs
Readers provide insight into the best companies to work for as well as the ups and downs of their jobs.

Pharmaceutical Technology
Volume 32, Issue 12, pp. 74-73

This month's "Viewpoint" column is attributed to the nearly 1200 industry participants who responded to our annual employment survey (see full coverage on "Is Job Security Throwing You Off Balance?"). Since 1988, the survey has provided a comprehensive look into the workforce of one of the world's largest industries: pharmaceuticals.

Best companies to work for

The questionnaire provided participants an opportunity to nominate their employer as one of the industry's "Best Companies to Work For." More than 250 employers were nominated by at least one employee. Nominations were evaluated according to employee benefits, employee attitudes toward their jobs, opportunity for professional advancement and raises, scientific challenge and problem-solving opportunities, communication among coworkers, and management's understanding of and communication to personnel of the company's goals .

Based on these criteria, the best pharmaceutical employers are:
  • Abbott Laboratories (North Chicago, IL). Abbott provides job satisfaction through valuable benefits and flexible work hours.
  • Covance (Madison, WI). Covance employees report good opportunities for scientific challenges, a positive work environment, and the firm's appreciation of diversity.
  • Genzyme (Cambridge, MA). Employees report high precentage of job security thanks to company growth and expanding research.
  • Eli Lilly (Indianapolis, IN). Eli Lilly actively recruits new graduates through student experience programs. The company's community responsibility program is highly regarded. Congratulations to these companies!

Survey participants were also asked to disclose what they like most and least about their jobs. Some common and unique responses are noted in the following sections.

Best aspects of jobs

"Challenging, demanding, and always new content."

"Human contact."

"Flexible schedule."

"Ability to mentor young technicians."

"Being in contact with peers around the world."

"Opportunity to meet high-level scientists."

"The products we make really do change people's lives."

"Scientific independence."

"My boss is 2500 miles away."

"Opportunity to deal with many different formulation challenges."

"Being on the forefront of technology."

"Spirit of enthusiasm."

"Salary increases."

"Location."

"Variety. You will not do the same thing year after year."

"Being recognized as an expert."

"The people."

"I control my pace and am able to stick to my eight hours a day."

"I get to see the entire industry as I conduct pharmaceutical inspections around the world."


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology,
Click here